Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

HER2-positive Breast Cancer 1

Interventions

Trastuzumab 14pertuzumab 10Docetaxel 9tucatinib 4Carboplatin 2Capecitabine 2Ado-Trastuzumab Emtansine 2trastuzumab deruxtecan 1pyrotinib 1margetuximab 1atezolizumab 1Paclitaxel 1Injections 1Hospital Information Systems 1Electronic Health Records 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × HER2-positive Breast Cancer × Electronic Health Records × Clear all
NCT05769751 2023-08-16

A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer

Daiichi Sankyo

Completed
865 enrolled
Breast

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡